Oral Acyclovir / Aciclovir and recurrent genital herpes during late pregnancy.OBJECTIVE. Complete healing was observed in 10 (77%) of the 13 treated patients. Results of foscarnet therapy.We retrospectively studied 18 consecutive cases of Acyclovir / Aciclovir-resistant zoster. Acyclovir / Aciclovir-resistant herpes zoster in antibiotics discount chemist warehouse melbourne human immunodeficiency virus-infected patients. Zoster relapsed after cessation of foscarnet therapy in five of the 10 responding patients. antibiotics The drug failed to suppress asymptomatic shedding of virus and transmission of HSV 2 to the neonate in sinusitis antibiotics one of five of the patients. Four patients died of varicella-zoster virus-associated visceral aciclovir complications.
The median time to relapse was 110 days. Fifteen of the 16 patients evaluable for previous Acyclovir / Aciclovir treatment had received aciclovir the drug. Plasma Acyclovir / Aciclovir peak and trough levels were determined. To assess plasma Acyclovir / Aciclovir levels in pregnant women acyclovir given oral Acyclovir / Aciclovir during late gestation and to determine the role and effect of oral Acyclovir / Aciclovir on asymptomatic shedding of virus in cases of antibiotic recurrent genital herpes. Viral cultures were obtained from both the mothers and neonates at delivery. These results show that Acyclovir / Aciclovir-resistant zoster has a poor prognosis but responds well to foscarnet therapy. Furthermore, Acyclovir / Aciclovir levels were comparable to those of nonpregnant adults. The mean number of previous zoster episodes was 1.53.
All the patients had chronic skin lesions that failed to heal despite treatment with intravenous Acyclovir / Aciclovir (30 mg/[kg.d]) in 15 cases and oral Acyclovir / Aciclovir (4 g/d) in three cases for > 10 days. Our study suggests that asymptomatic shedding of virus is not prevented by use of oral Acyclovir / Aciclovir during late gestation in proven recurrent genital herpes even though plasma Acyclovir / Aciclovir levels were within the normal range.. Thirteen patients were treated with intravenous foscarnet (200 mg/[kg.d]) for a mean of 17.8 days. Oral Acyclovir / Aciclovir was administered every 8 hours at dosages of 300, 400, and 300 mg in two subjects, and 200 mg five times daily in the other three until delivery. Five pregnant women with proven genital herpes isolate (herpes simplex virus [HSV] 2) after 37 weeks' gestation were studied.
The mean CD4 cell count was 20 x 10(6)/L. There was no difference in Acyclovir / Aciclovir plasma levels among the patients.
.